Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic

  • Search Hotels in Pleasanton

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Shockwave Medical Inc (NQ: SWAV )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Shockwave Medical Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
7 Overlooked Stocks That Belong in Every Portfolio
Looking beyond the headlines creates an opportunity for investors who have the patience to seek must-own overlooked stocks. 
Via InvestorPlace
Why Sarepta Therapeutics Stock Is Rising Today
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stock is trading higher on Thursday after it was announced the company will be added to the S&P MidCap 400. 
Via Benzinga
Topics Stocks
Exposures US Equities
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
Johnson & Johnson acquires Proteologix for $850 million, expanding its bispecific antibody portfolio for immune-mediated diseases. 
Via Benzinga
Exploring the Growth Potential of NASDAQ:SWAV as It Nears a Breakout.
SHOCKWAVE MEDICAL INC (NASDAQ:SWAV), a strong growth stock, setting up for a breakout. 
Via Chartmill
SWAV Stock Earnings: ShockWave Medical Beats EPS, Beats Revenue for Q1 2024
SWAV stock results show that ShockWave Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
NASDAQ:SWAV: a strong growth stock preparing for the next leg up?.
Is SHOCKWAVE MEDICAL INC (NASDAQ:SWAV) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
Johnson & Johnson Is a King of Dividend Safety
The healthcare behemoth has fortified its dividend. 
Via The Motley Fool
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
The medical device market is growing fast, and top medical device firms can become takeover targets. Here are three medtech stocks to watch. 
Via InvestorPlace
Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.
Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder. 
Via InvestorPlace
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost... 
Via Benzinga
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024
In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024. 
Via InvestorPlace
All-Time High Flyers: 7 Stocks to Buy as the Market Peaks
These stocks to buy have enjoyed big rallies and the gains look likely to continue in coming months even if the market does peak. 
Via InvestorPlace
5 Things To Know In Investing This Week - The Shockwave Takeover Issue
The Shockwave offer that DKI predicted in December happened this week with Johnson & Johnson (NYSE: JNJ)agreeing to pay $335 per share in cash. DKI subscribers celebrated! The PMI came in  hot. Don’t... 
Via Benzinga
Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024
These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating. 
Via InvestorPlace
Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?
The company is hoping to expand, but is there enough here to attract growth investors? 
Via The Motley Fool
3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade
Income-seeking investors can look forward to steady payout raises from these pharma stocks. 
Via The Motley Fool
Johnson & Johnson's $13B Shockwave Medical Deal Accelerates MedTech Strategy, Analyst Says
Johnson & Johnson acquires Shockwave Medical, bolstering its presence in cardiovascular intervention. The move marks a strategic shift, with around $30 billion invested in MedTech over 18 months. 
Via Benzinga
Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Market Rally Under Pressure; Tesla, Humana In Focus: Weekly Review
The indexes and leading stocks are generally holding key levels. 
Via Investor's Business Daily
Wells Fargo Is Pounding the Table on Cinemark (CNK) Stock
Cinemark stock is up on Friday following a double upgrade and increased price target from Wells Fargo analysts for CNK shares. 
Via InvestorPlace
BTIG Just MASSIVELY Raised Its Price Target on MicroStrategy (MSTR) Stock
MicroStrategy stock is up on Friday after shares of MSTR got an increased price target from BTIG analysts and a buy rating. 
Via InvestorPlace
SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson
JNJ is building a suite of heart disease treatment devices and hopes integration can help it avoid a patent cliff. 
Via InvestorPlace
Topics Intellectual Property
Exposures Intellectual Property
Johnson & Johnson Makes Yet Another Multi-Billion MedTech Deal With Shockwave Medical
Johnson & Johnson to acquire Shockwave Medical for $335.00/share in cash, bolstering its cardiovascular intervention portfolio. The acquisition, expected to close by mid-2024, signifies Johnson &... 
Via Benzinga
Johnson & Johnson To Buy Shockwave Medical For $13.1 Billion
The Dow giant will pay $335 a share for Shockwave following takeover buzz. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
5 Things to Know in Investing This Week
The Shockwave Issue 
Via Benzinga
Domino's Pizza To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
These advantaged businesses have what it takes to keep raising their payouts. 
Via The Motley Fool
Why Shockwave Medical Stock Rallied as Much as 18% Higher This Week
Buyout rumors and love from Wall Street propelled the stock to double-digit gains. 
Via The Motley Fool
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst
Johnson & Johnson reportedly in talks to acquire Shockwave Medical. Potential acquisition aligns with J&J's interest in expanding into cardiovascular devices. Piper Sandler considers J&J a potential... 
Via Benzinga
Shockwave Medical Stock Sees Relative Strength Rating Ride Higher
On Wednesday, Shockwave Medical stock got a positive adjustment to its Relative Strength (RS) Rating, from 90 to 94. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photography by Christophe Tomatis
Copyright © 2010-2020 Pleasanton.com & California Media Partners, LLC. All rights reserved.